Zafgen's Series B - III Round

Zafgen raised a round of funding on March 19, 2010.

Zafgen is a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity. Beloranib, Zafgen's lead product candidate, is a novel, first-in-c…

Articles about Zafgen's Series B - III Round: